News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
824,373 Results
Type
Article (85264)
Company Profile (622)
Press Release (738487)
Section
Business (231858)
Career Advice (4090)
Deals (39621)
Drug Delivery (106)
Drug Development (90429)
Employer Resources (192)
FDA (17887)
Job Trends (17246)
News (394622)
Policy (39583)
Tag
Academia (2973)
Africa (1262)
Alliances (56336)
Alzheimer's disease (1244)
Approvals (17793)
Arizona (210)
Artificial intelligence (86)
Asia (48998)
Australia (8615)
Bankruptcy (392)
Best Places to Work (12251)
Biotechnology (438)
C2C Services and Suppliers (95111)
California (2000)
Canada (937)
Cancer (527)
Career advice (3497)
Cell therapy (140)
China (154)
Clinical research (70420)
Collaboration (151)
Colorado (82)
Compensation (82)
Connecticut (82)
COVID-19 (2753)
Cystic fibrosis (77)
Data (297)
Diabetes (91)
Diagnostics (6496)
Drug pricing (82)
Earnings (93521)
Employer resources (162)
Europe (112004)
Events (124990)
Executive appointments (158)
FDA (18105)
Florida (271)
Funding (151)
Gene therapy (106)
GLP-1 (618)
Government (5007)
Healthcare (20650)
Hotbed/Location (534575)
Illinois (321)
Indiana (161)
Infectious disease (2784)
Inflammatory bowel disease (102)
Interviews (805)
IPO (17488)
Job creations (5172)
Job search strategy (2849)
Kansas (100)
Layoffs (467)
Legal (10012)
Lung cancer (125)
Manufacturing (100)
Maryland (428)
Massachusetts (1708)
Medical device (14262)
Medtech (14267)
Mergers & acquisitions (21959)
Metabolic disorders (295)
Michigan (136)
Minnesota (236)
Neuroscience (1406)
New Jersey (610)
New York (613)
NextGen Class of 2024 (7622)
Non-profit (5052)
North Carolina (699)
Northern California (838)
Obesity (176)
Ohio (110)
Opinion (234)
Patents (75)
Pennsylvania (589)
People (63715)
Pharmaceutical (119)
Phase I (21621)
Phase II (30572)
Phase III (23101)
Pipeline (110)
Podcasts (75)
Postmarket research (3532)
Preclinical (9765)
Press Release (72)
Rare diseases (140)
Real estate (7361)
Recruiting (72)
Regulatory (25587)
Research institute (2633)
Resumes & cover letters (645)
South America (1641)
Southern California (768)
Startups (4272)
Texas (264)
United States (9299)
Vaccines (563)
Washington State (280)
Weight loss (168)
Date
Today (108)
Last 7 days (722)
Last 30 days (2473)
Last 365 days (40074)
2024 (28035)
2023 (42566)
2022 (53929)
2021 (58727)
2020 (57671)
2019 (51341)
2018 (39126)
2017 (37193)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36269)
2012 (38416)
2011 (38383)
2010 (39616)
There are 824,373 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Omega Therapeutics Announces Publication of Epigenomic Controller OTX-2002 Preclinical Data in Nature Communications
September 18, 2024
·
7 min read
Business
Altamira Therapeutics Announces Pricing of up to $12.0 Million Public Offering
September 17, 2024
·
6 min read
Business
Kodiak Sciences to Host Investor R&D Day on September 23, 2024 in New York City
September 17, 2024
·
10 min read
Business
Appili Therapeutics Announces Results of Annual and Special Meeting of Shareholders
September 17, 2024
·
2 min read
Business
Kairos Pharma Closing of $6.2 Million Initial Public Offering
September 17, 2024
·
4 min read
Business
Edgewise Therapeutics to Host Webcast Event to Discuss Top-Line Data from Phase 1 trial in Healthy Subjects and Phase 2 CIRRUS-HCM Trial in Patients with Obstructive Hypertrophic Cardiomyopathy (HCM) on Thursday, September 19 at 8:30 am Eastern Time
September 17, 2024
·
1 min read
Drug Development
Revalesio’s Investigational RNS60 Extended Survival in Patients with Amyotrophic Lateral Sclerosis (ALS) in Post-Hoc Analysis of Phase 2 Investigator-Sponsored Trial
September 17, 2024
·
4 min read
Drug Development
Rocket Pharmaceuticals Announces Completion of Enrollment in Phase 2 Pivotal Trial of RP-A501 for the Treatment of Danon Disease
September 17, 2024
·
9 min read
Business
Mirador Therapeutics Appoints Gregg Gilbert at Chief Financial Officer
September 17, 2024
·
2 min read
Drug Development
Biogen’s New Drug Submission for Omaveloxolone Accepted for Priority Review by Health Canada for the Treatment of Friedreich’s Ataxia
September 17, 2024
·
3 min read
1 of 82,438
Next